3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Lymphoma
17
Leukemia, Myeloid, Acute
16
Breast Neoplasms
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Multiple Myeloma
12
Lymphoma, Large B-Cell, Diffuse
12
Lymphoma, Non-Hodgkin
11
Carcinoma, Non-Small-Cell Lung
11
Lymphoma, Mantle-Cell
10
Leukemia
10
Lymphoma, Follicular
9
Hodgkin Disease
9
Myelodysplastic Syndromes
8
Recurrence
7
Neuroblastoma
7
Neoplasm Metastasis
7
Leukemia, Lymphocytic, Chronic, B-Cell
7
Brain Neoplasms
7
Neoplasms, Plasma Cell
6
Lymphoma, B-Cell, Marginal Zone
6
Lung Neoplasms
6
Glioblastoma
6
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, T-Cell
5
Lymphoma, Large-Cell, Anaplastic
5
Lymphoma, B-Cell
5
Immunoblastic Lymphadenopathy
5
Burkitt Lymphoma
5
Interventions
Cisplatin
101
Radiotherapy
53
Brachytherapy
41
Paclitaxel
37
Carboplatin
36
Surveys and Questionnaires
28
Blood Specimen Collection
20
pembrolizumab
19
Radiation
17
Magnetic Resonance Spectroscopy
17
Drug Therapy
17
Colposcopy
16
Methods
14
Bevacizumab
14
Early Intervention, Educational
12
toripalimab
11
Topotecan
11
Radiotherapy, Intensity-Modulated
11
Papanicolaou Test
11
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
11
Chemoradiotherapy
11
Biopsy
11
camrelizumab
10
Mass Screening
10
Gemcitabine
10
Patient Navigation
9
Papillomavirus Vaccines
9
Nivolumab
9
Fluorodeoxyglucose F18
9
Educational Status
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Neoplasms
×
Vorinostat
×
Clear all
NCT04357873
2025-02-19
PEVOsq
UNICANCER
Phase 2
Completed
112 enrolled